Business
RFK Jr.’s vaccine panel postpones vote on whether to delay babies’ first hepatitis B shot
Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine panel on Friday postponed a vote on whether to delay the first dose of the hepatitis B shot from birth to at least one month for most babies born in the U.S.
The decision means that the committee’s current recommendation – that all infants receive a hepatitis B vaccine within 24 hours of birth – will stay in place until the group meets again at a later date. It’s unclear when the panel, called the Advisory Committee on Immunization Practices, or ACIP, will convene again to discuss the hepatitis B shot.
ACIP was considering whether to delay the first dose of the vaccine until at least one month of age for babies of women who test negative for hepatitis B. That would change a safe and highly effective birth dose recommendation that was introduced in 1991 and is credited with virtually eliminating the disease in young kids.
Some advisors defended the birth dose recommendation during the meeting, saying that delaying it could introduce potential risks to babies, including more infections. But others, particularly those who are known vaccine critics, cast doubt on the safety of administering the vaccine to babies so soon.
Dr. Robert Malone, who gained notoriety for promoting Covid misinformation, brought the motion to postpone the vote.
“I believe that there’s enough ambiguity here and enough remaining discussion about safety, effectiveness and timing that I believe that a vote today would be premature,” Malone said.
All 12 members supported the motion. Dr. Cody Meissner, a professor of pediatrics at the Dartmouth Geisel School of Medicine, said, “I don’t think there’s any question whatsoever that the benefit [of the birth dose] far outweighs any adverse side effects.”
The postponed vote only affects the timing of the first dose of the hepatitis B vaccine series. The second would still be given one-to-two months after birth, with a third dose between six and 18 months of age.
Also on Friday, the group voted to recommend hepatitis B testing for all pregnant women. The Centers for Disease Control and Prevention, whose most recent director was ousted by the Trump administration, has to sign off on the committee’s new and future recommendations.
The panel’s closely watched two-day meeting in Atlanta comes after Kennedy gutted the committee and appointed 12 new members, including some well-known vaccine critics. ACIP sets recommendations on who should receive certain shots and which vaccines insurers must cover at no cost, raising concerns among health experts that Kennedy’s reshaped panel could curb access to safe and effective immunizations.
The hepatitis B shot has been a life-saving public health intervention against the disease, which can lead to severe health problems, including liver cancer and failure, and death. Acute hepatitis B infections reported among children and teens dropped by 99% between 1990 and 2019, some studies said. The American Academy of Pediatrics says that the so-called birth dose is critical to reduce chronic hepatitis B later in life.
On Thursday, advisors and other scientific experts clashed over the safety of the birth dose.
“I believe that this vaccine is absolutely critical for babies that are treated,” said member Retsef Levi, who has been vocal about his opposition to RNA vaccines. “But this notion that we sit here with very lousy evidence and argue there is no problem whatsoever [with administering the shot at birth] is not building trust, and it’s not scientific and it’s not what the public here should expect from us.”
But Meissner said that changing the recommendation will “increase the risk of harm based on no evidence of benefit.” He said there will be fewer children who get the full hepatitis B vaccine series, adding that administering the shot at birth in the hospital ensures that babies at least receive their first dose.
“As people have asked, why would we pick one month? Why two? There’s no evidence that it’s safer at a later time,” Meissner said. “It’s an extremely safe vaccine, a very pure vaccine. So I think we will be creating new doubts in the minds of the public that are not justified.”
Ahead of the vote, the American Medical Association strongly urged the panel to keep the birth dose recommendation in place. Other experts outside of the panel also expressed concern about changing the guidance.
“I have not seen any data that says that there is benefit to the infant of waiting a month but there are a number of potential harms to the incident of waiting a month,” said Dr. Adam Langer, a CDC epidemiologist who gave a presentation on the hepatitis B birth dose, ahead of the vote.
During his presentation, Langer said, “the sooner that the hepatitis B vaccine is provided after birth, the greater its effectiveness in preventing perinatal transmission.” That refers to when an infant becomes infected from its mother during birth.
Merck, which manufactures one of the vaccines used starting at birth, pushed back on the proposed recommendation ahead of the panel’s official vote on Thursday.
“The reconsideration of the newborn Hepatitis B vaccination on the established schedule poses a grave risk to the health of children and to the public, which could lead to a resurgence of preventable infectious diseases,” Dr. Richard Haupt, Merck’s head of global medical and scientific affairs for vaccines and infectious diseases, said during the meeting.
GSK manufactures another hepatitis B shot starting at birth.
Business
Indians cut overseas travel spending to $1.9 billion in March: RBI
Indians sharply cut back on overseas travel spending in March, with remittances for foreign trips dropping by more than $212 million from the previous month, according to Reserve Bank of India data. The fall in outbound travel expenditure came amid rising oil prices linked to the Middle East conflict and persistent pressure on rupee, even as travel remained the single largest component of outward remittances under the Liberalised Remittance Scheme (LRS).In March, travel-related remittances fell to $1.09 billion from $1.3 billion in February and $1.65 billion in January. The decline came at a time when the West Asia conflict pushed oil prices higher and weakened rupee to record lows. Amid the situation, Prime Minister Narendra Modi urged citizens to cut down on foreign travel and adopt measures such as carpooling. Lower overseas travel spending could reduce foreign exchange outflows and help ease pressure on rupee.According to the RBI’s data on outward remittances by resident individuals, travel continued to account for the largest share of money sent abroad under the LRS in March. Total remittances during the month stood at $2.59 billion.The RBI tracks overseas spending across categories including travel, studies abroad, maintenance of close relatives, overseas investments, and property purchases. Under the LRS framework, resident individuals, including minors, can remit up to $250,000 in a financial year for permitted current or capital account transactions.Within the travel segment, the biggest component remained the ‘other travel’ category, which covers holiday spending and international credit card settlements. Indians spent $623.05 million under this category in March, accounting for nearly 57 per cent of total travel-related remittances during the month.Expenditure linked to education travel, including hostel and fee payments, stood at $450.16 million. Business travel, pilgrimage, and overseas medical treatment together accounted for $21.39 million.The data also showed a rise in remittances meant for the maintenance of close relatives abroad. Such transfers increased to $389.78 million in March from $266.18 million in February.At the same time, spending under the ‘studies abroad’ category declined. This category includes payments made for educational services accessed remotely without travelling overseas, such as correspondence courses. Remittances under this head stood at $151.71 million in March, compared to $175.68 million in February and $267.42 million in January.For the financial year 2024-25, Indians remitted a total of $29.56 billion under the LRS. Travel made up the largest portion of this amount at $16.96 billion.The RBI figures further showed that investments by Indians in overseas equity and debt instruments rose significantly to $440.22 million in March from $265.99 million in February.Meanwhile, outward remittances for the purchase of immovable property overseas declined to $38.68 million in March, down from $51.36 million a month earlier.
Business
Stock market this week: Middle East tensions, oil prices, FII flows & more — what will guide Dalal Street
Dalal Street is heading into the new trading week with global uncertainty firmly in focus, as investors keep a close watch on the evolving situation in the Middle East, fluctuations in crude oil prices and the behaviour of foreign investors. Analysts said that sentiment is likely to remain fragile and heavily influenced by developments in negotiations between the United States and Iran, while movements in the rupee, global equities and the US dollar are also expected to shape market direction in the days ahead.Trading activity during the week is also expected to be shaped by the rupee’s movement against the US dollar, while investors continue to assess the impact of global uncertainty on risk appetite. Markets will remain closed on Thursday for Bakri Id.A key trigger for sentiment emerged over the weekend after US Secretary of State Marco Rubio said negotiations between Washington and Tehran had shown some progress, raising expectations that the ongoing conflict in West Asia could move closer to resolution.Ajit Mishra, SVP, Research at Religare Broking Ltd, said investors would closely track developments tied to crude oil, global currencies and bond markets. “This week is expected to remain highly sensitive to global macroeconomic developments and currency movements. Investors will also monitor crude oil prices, developments in US-Iran negotiations, and the trajectory of the US dollar and bond yields, all of which are expected to influence foreign flows and overall risk appetite,” he said.Apart from geopolitical developments, the Reserve Bank’s decision to transfer a record Rs 2.87 lakh crore dividend to the government for the year ended March 2026 is also expected to remain in focus. The announcement comes at a time when rising import costs and supply chain pressures linked to the West Asia conflict continue to weigh on the economy.According to Mishra, market participants are expected to evaluate how the RBI payout could affect liquidity conditions, fiscal flexibility and government spending in the months ahead.Ponmudi R, CEO of Enrich Money, said market behaviour in the coming sessions is expected to remain sensitive to fresh headlines surrounding diplomatic negotiations and oil prices. “Markets are expected to remain volatile and heavily headline-driven in the coming week, with investor attention firmly focused on developments surrounding the US–Iran situation, broader diplomatic negotiations and movements in crude oil prices,” he said.“While hopes of a diplomatic breakthrough and easing geopolitical tensions have improved sentiment modestly, investors continue to remain cautious as uncertainty surrounding the final outcome of the negotiations remains elevated,” Ponmudi added.He further said investors are expected to watch institutional flows, global equity trends, macroeconomic indicators and the rupee for further market cues. “With global uncertainty still elevated, market participants are likely to remain selective and cautious despite the recent improvement in sentiment,” he said.Vinod Nair, Head of Research at Geojit Investments Limited, said markets would require stronger support factors to build a more constructive setup. According to him, a meaningful decline in crude oil prices, steady foreign institutional investor flows and stable Q1FY27 earnings expectations without major downgrades would be important for sustained momentum.In the previous week, the BSE benchmark index rose 177.36 points, or 0.23%, while the NSE Nifty advanced 75.8 points, or 0.32%.
Business
‘Shameful’ more spent on benefits than jobs for young people, says adviser Alan Milburn
Reforms are needed of the welfare system to tackle the high numbers of young people not in work or education, says Alan Milburn.
Source link
-
Entertainment1 week agoWhere Pete Davidson, Elsie Hewitt stand after breakup: Details revealed
-
Politics1 week agoRising diesel costs from Iran war strain US school budgets
-
Tech1 week agoWhy Is Your Grill So Dumb? The Best Grills Set Temp Like an Oven
-
Tech1 week agoThis Solar-Powered Smart Sprinkler Keeps My Lawn Watered Without Any Power Cables
-
Fashion1 week agoRMG trade bodies seek policy support from Bangladesh PM
-
Tech1 week agoTesla Reveals New Details About Robotaxi Crashes—and the Humans Involved
-
Fashion6 days agoNigeria Kwara Garment Factory, KWS Garment Production Village ink pact
-
Sports1 week agoPakistan steady after Das ton | The Express Tribune
